Management of cutaneous immune-related adverse events from immune checkpoint inhibitor therapy

OTC: over the counter; ICI: immune checkpoint inhibitor; GABA: gamma-aminobutyric acid; NBUVB: narrowband ultraviolet B; IL: interleukin; TNF: tumor necrosis factor.

From: Phillips GS, Wu J, Hellmann MD, et al. Treatment Outcomes of Immune-Related Cutaneous Adverse Events. J Clin Oncol 2019; 37:2746. DOI: 10.1200/JCO.18.02141. Copyright © 2019 American Society of Clinical Oncology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.

Graphic 134200 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟